PHARMEDAILY

Backed by Teva, Prestige Biopharma Accelerates Biosimilar Rollout in Europe

• 유진희
• 2025.05.29
• 오전 08:02

3billion, Prestige BioPharma Jump on Tariff Optimism[K-bio Pulse]

• 석지헌
• 2025.04.11
• 오전 08:00

Prestige Biologics Order Backlog Tops KRW 30 Billion, Marking Growth Milestone

• 송영두
• 2025.03.25
• 오전 07:52